ARCHIVES

Kerrie Wilson Succeeds Alan Davis As ACS Chief Lobbyist

This article is from The Cancer Letter archive.

Vol. 19 No. 46 | November 26, 1993

Download PDF Visit The Full Archive

Related Articles

NCI’s Chabner Cautions Against 3-Hour Taxol Infusion, May Lower Response Rate

October 22, 1993

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

October 14, 2005

Cancer Rates Keep Falling, NCI’s Progress Report Says.

December 7, 2001

In This Issue: Congressional Testimony On NIH, NCI Appropriations, FDA Reform

May 9, 1997

Telatinib Demonstrates Positive Results in First-Line Treatment

June 24, 2011

New Guidelines Developed For Cooperative Group Grant Review

August 17, 1979